PANACEA LIFE SCIENCES HOLDINGS, INC. Annual Depreciation in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Panacea Life Sciences Holdings, Inc. quarterly/annual Depreciation history and growth rate from 2018 to 2023.
  • Panacea Life Sciences Holdings, Inc. Depreciation for the quarter ending March 31, 2024 was $383K, a 9.24% decline year-over-year.
  • Panacea Life Sciences Holdings, Inc. Depreciation for the twelve months ending March 31, 2024 was $1.67M, a 0.57% decline year-over-year.
  • Panacea Life Sciences Holdings, Inc. annual Depreciation for 2023 was $1.71M, a 2.59% increase from 2022.
  • Panacea Life Sciences Holdings, Inc. annual Depreciation for 2022 was $1.67M, a 0.36% decline from 2021.
  • Panacea Life Sciences Holdings, Inc. annual Depreciation for 2021 was $1.68M, a 2.77% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.71M +$43.3K +2.59% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $1.67M -$6.1K -0.36% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $1.68M +$45.2K +2.77% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $1.63M +$1.57M +2457% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $63.8K +$63.8K Jan 1, 2019 Dec 31, 2019 10-K/A 2021-04-23
2018 $0 Jan 1, 2018 Dec 31, 2018 10-K 2020-05-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.